RCA
MRNA icon

Ranch Capital Advisors’s Moderna MRNA Stock Holding History

Ranch Capital Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,231
Closed -$221K – 153
2022
Q4 		$221K Sell
1,231
-861
-41% -$141K 0.17% 134
2022
Q3 		$247K Buy
+2,092
New +$317K 0.2% 132
2022
Q2 		– Sell
-1,363
Closed -$235K – 159
2022
Q1 		$235K Sell
1,363
-220
-14% -$37K 0.16% 141
2021
Q4 		$402K Sell
1,583
-19
-1% -$5.55K 0.26% 105
2021
Q3 		$617K Buy
+1,602
New +$591K 0.39% 78
2021
Q2 		– Sell
-1,421
Closed -$254K – 114
2021
Q1 		$186K Buy
1,421
+416
+41% +$60.3K 0.12% 157
2020
Q4 		$104K Buy
1,005
+385
+62% +$38.9K 0.07% 202
2020
Q3 		$43K Hold
620
– – 0.03% 312
2020
Q2 		$44K Buy
620
+395
+176% +$21.6K 0.03% 325
2020
Q1 		$6K Buy
+225
New +$5.18K 0.01% 685

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ranch Capital Advisors's MRNA Position: Q1 2023 in Review

Ranch Capital Advisors sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,231 shares — an estimated $221K sold.

Ranch Capital Advisors first reported a position in MRNA in Q1 2020 and held it in 10 quarters. The position peaked at $617K in Q3 2021. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Ranch Capital Advisors reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Ranch Capital Advisors sold 1,231 Moderna shares in Q1 2023, an estimated $221K.
  • Ranch Capital Advisors first reported a position in Moderna in Q1 2020 and held it in 10 quarters.
  • Ranch Capital Advisors's Moderna position peaked at $617K in Q3 2021.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Ranch Capital Advisors's 13F filing for Q1 2023, filed 12 May 2023.